Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

(MedPage Today) — FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial.
In its premarket approval application for the Ventura Interatrial Shunt…

Source link : https://www.medpagetoday.com/cardiology/chf/118788

Author :

Publish date : 2025-12-02 17:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

Polypharmacy Is a Real Issue. Dismantling Public Health Won’t Fix It.

Delaying Hep B Vaccine in Infants Carries Significant Risks, Report Warns

Related Posts

Nivolumab-Ipilimumab Not Cost-Effective for Liver Cancer

Period blood test could be alternative to cervical screening, study says

Autism Prevalence in Girls and Boys May Be Nearly Equal, Study Suggests

‘Time Is Brain’ Again, Now for Hemostatic Control of Intracerebral Bleeds

Dems Hijack CMS Fraud Hearing, Cast Spotlight on ‘Federal Terror’ Campaign

Heart Attack, Stroke Risk Rises After Serious RSV, Study Says

Nivolumab-Ipilimumab Not Cost-Effective for Liver Cancer

Period blood test could be alternative to cervical screening, study says

Autism Prevalence in Girls and Boys May Be Nearly Equal, Study Suggests

‘Time Is Brain’ Again, Now for Hemostatic Control of Intracerebral Bleeds

Dems Hijack CMS Fraud Hearing, Cast Spotlight on ‘Federal Terror’ Campaign

Heart Attack, Stroke Risk Rises After Serious RSV, Study Says

More Evidence That Removing Fallopian Tubes Dramatically Reduces Ovarian Cancer Risk

‘Most Compelling’ Data Yet for Metastasis-Directed Therapy in Prostate Cancer

Categories

Archives